Clinical Approach to Syncope in Children

download Clinical Approach to Syncope in Children

of 6

description

Semin Pediatr Neurol 20:12-172013

Transcript of Clinical Approach to Syncope in Children

  • Clinical Approach to SyncopManikum Moodley, MBChB, FRCP

    mmo riche em ssala nd

    ncopthoratienprovpro

    of syevier Inc. All rights reserved.

    such as nausea, epigastric discomfort, blurred or tunnel

    vision, muffled hearing, dizziness, light-headedness, dia-

    clammy skin, or w

    any combination

    from 1 episodesyncope are beni

    life-threatening c

    more, the term sdifferent people,

    asked to help di

    chogenic, and me

    rate of syncope ranges from 33%-51% when patients are

    followed for up to 5 years.4

    a comprehensiveing syncope intocardiovascular-mediated syncope is less frequent thanit is in adults.8 The differential diagnosis of syncope is

    given in Table 1.

    12 1071-9091/11/$-see front matter & 2013 Elsevier Inc. All rights reserved.

    Address reprint requests to Manikum Moodley, MBChB, FRCP, Center for

    Pediatric Neurology, Neurological Institute, Cleveland Clinic Founda-

    tion, 9500 Euclid Ave/ S60, Cleveland, OH 44195. E-mail:

    [email protected] cases of syncope in adults but in children(c) Noncardiovascular syncope.

    Neurally mediated syncope and cardiovascular-mediated syncope, each accounts for about 50% ofFrom the Center for Pediatric Neurology, Neurological Institute, Cleveland

    Clinic Foundation, Cleveland, OH.http://dx.doi.oeakness.4 These symptoms may occur in

    or be variably present in any given patient

    to the next.4 Most cases of pediatricgn but an evaluation must exclude a rare

    ardiac or noncardiac disorder. Further-

    yncope may have different meanings totherefore specific questions should be

    fferentiate cardiac from neurologic, psy-

    tabolic conditions.

    EtiologyA detailed history of the event followed byphysical examination will help in categoriz

    the 3 major categories:

    (a) Neurally mediated syncope(b) Cardiovascular mediated syncopephoresis, hyperventilation, palpitations, pallor, cold andPediatric syncope is one of the most copopulation in both the office setting and in tof consciousness is usually dramatic andproviders. The differential diagnosis of sycomprehensive but focused history and acornerstones in the diagnosis of high-risk psyncope in children is costly and testingreviews the various types of syncope anddiagnosis, investigation, and managementSemin Pediatr Neurol 20:12-17 C 2013 Els

    IntroductionSyncope is defined as the abrupt loss of consciousness and

    postural tone resulting from transient global cerebralhypoperfusion followed by spontaneous complete recov-

    ery.1 Presyncope is the feeling that one is about to pass out

    but remains conscious with a transient loss of posturaltone.2

    In the young patient, syncope often results from a fall in

    systolic pressure below 70 mmHg or a mean arterialpressure of 30-40 mmHg.3,4 The syncopal event is typically

    preceded by a prodrome lasting from several seconds to 1-2

    minutes characterized by distinctive premonitory featuresrg/10.1016/j.spen.2012.12.003EpidemiologySyncope is a common pediatric problem, affecting 15%-

    25% of the children and adolescents.4 The incidence peaksbetween the ages of 15 and 19 years for both sexes but

    there appears to be a female predominance.5 Before age 6,

    syncope is unusual except in the setting of seizures, breath-holding spells, and cardiac arrythmias.1 In contrast to

    adults, neurocardiogenic syncope or vasovagal syncope or

    vasodepressor syncope is the most frequent cause ofpediatric syncope (61%-80%).6 Syncope secondary to

    orthostatic hypotension is frequent in the very old but rare

    in individuals less than 40 years of age.7 The recurrencee is wide but most cases are benign. Aough clinical examination are usually thets. It should be noted that the evaluation ofides a low diagnostic yield. This chaptervides a succinct clinical approach to thencope in children.ergrminency department. The abrupt brief log to patients, family, onlookers, an neurological problems in the pediate in Children

  • Table 1 Differential Diagnosis of Pediatric Syncope*

    Cardiovascular mediated syncope Neurocardiogenic syncope (vasodepressor vasovagal) Orthostatic hypotension Postural orthostatic tachycardia syndrome (POTS) Convulsive syncope Reflex syncope Psychogenic syncope/ panic attacks/ hyperventilation Situational syncope

    J CoughingJ SneezingJ MicturitionJ DefecationJ Deglutition (cold liquids)

    *

    Clinical approach to syncope in children

    TabPe

    Cardiovascular-mediated syncopeCardiovascular-mediated syncope has a higher mor-

    tality and higher incidence of sudden death than

    neurally mediated syncope.4 A detailed cardiac his-tory is, therefore, of paramount importance and red

    HypoglycemiaJ Electrolyte disorderJ Endocrine disorder

    Modified and reprinted with permission.4J Hair groomingJ Trumpet playingJ SuffocationJ Weight liftingJ DivingJ Stretching

    Drug and toxin inducedMetabolicJflags in the history that signal a need for an urgent

    pediatric cardiology referral are given in Table 2.Cardiovascular causes of syncope in children are

    given in Table 3.

    Neurocardiogenic syncopeNeurocardiogenic syncope, previously known as vaso-

    depressor, vasovagal, or neurally mediated syncope, is

    the most common cause of syncope. The history thatsuggests this type of benign syncope includes triggers

    such as postural changes, prolonged standing or

    sitting, obnoxious stimuli (anger, pain, sight ofblood), and a positive family history is often elicited.

    le 2 History of Red Flags Requiring Urgent Referral todiatric Cardiology

    History of heart murmur or congenital heart diseaseAcute attacks associated with hyperpnea or cyanosisSyncope during exercise, including swimming or withexertionFamily history of early sudden cardiac death, long QTsyndrome, sensorineural hearing loss, familial heartdiseaseMedications that can result in long QT syndrome,arrhythmiasAbsence of usual premonitory symptoms or precipitatingfactors associated with neurally mediated syncopeUnusual syncope triggers such as loud noises, fright, orextreme emotional stressClinical FeaturesThe diagnosis of syncope rests mainly on clinical grounds

    but the lack of objective findings in pediatric syncope often

    poses a challenge to caregivers. A thorough history with adetailed physical examination and electrocardiography

    (EKG) have a combined diagnostic yield of about 50%.3

    A detailed history should include the time of day, time oflast meal, activities leading up to the event, and associated

    symptoms such as light-headedness, dizziness, palpitations,

    Table 3 Cardiovascular Causes of Syncope*

    K ArrhythmiasComplete heart blockSick sinus syndromeTachyarrhythmias:J Supraventricular (Wolff-Parkinson-White-

    syndrome)J Ventricular

    Ion channel abnormalitiesJ Long QT syndrome (congenital or drug

    induced)J Brugada syndrome

    Arrhythmogenic right ventricular diseaseK Cardiacstructural

    Valvular aortic stenosisHypertrophic obstructive cardiomyopathyCoronary artery anomaliesPrimary pulmonary hypertensionEisenmenger syndromeMitral valve prolapseNeuromuscular disorders

    K Cardiac tumors

    *Modified and reprinted with permission.4

    13chest pain, headache, shortness of breath, nausea, pallor,diaphoresis, visual changes, and auditory changes. When

    these clinical features are present, they help to differentiate

    syncope from epilepsy.4 A detailed history usually revealscontributory environmental factors before the syncopal

    events (upright posture, prolonged standing, change in

    posture, crowding, heat, fatigue, hunger, or a concurrentillness).9 The loss of consciousness is usually brief, lasting

    from a few seconds to 1-2 minutes, followed by rapid

    spontaneous recovery without neurologic deficits.4 Duringthe episode the patient may have tonic posturing or a brief

    clonic seizure, rarely associated with urinary incontinence.

    In addition to the pertinent medical history, a family historyof familial heart disease, congenital heart disease, metabolic

    disease, medication history, pregnancy, and psychiatric

    history should be gathered.Distinguishing between neurocardiogenic syncope and

    seizures is the most common clinical dilemma faced by care

    providers, whereas, in distinguishing patients with syncopedue to cardiac causes a history and physical examination can

    be 95% sensitive for a cardiac etiology.10 Patients with

    pseudosyncope and pseudoseizures typically use the eventsconsciously or unconsciously to avoid an unpleasant emo-

    tional situation.11 Most of these patients are females with a

    very high number of events, florid symptomatology, and

  • logic causes of syncope, and should also include orthostatic

    will guide practitioners in choosing the diagnostic studies

    who had recurrent syncope, tilt table testing at 801 for 30

    Table 4 Key Elements in the History of Pediatric Syncope*

    Patient Hydration status Environmental conditions Activity immediately before syncopal event Frequency and duration of the episode Historical data from witnesses Complete drug history Exercise induced syncope Menstrual history

    Family History of syncope or cardiac disease Sudden unexplained death in children or young adults Family history of seizures Familial deafness Pacemaker placement*Modified and reprinted with permission.4

    1. Hematologicalbiochemical CBC Serum iron, TIBC, ferritin CMP

    2. Cardiac evaluation EKG Echocardiography Holter or event monitor.

    3. Autonomic evaluation Neurocardio autonomic reflex testing with and with-

    out tilt table testing Quantitative sudomotor axon reflex test (QSART) Thermoregulatory sweat test (TST).

    4. Miscellaneous Urine specific gravity Urinary sodium levels Pregnancy test in all menstruating females.

    EEG, CT, and MRI of the brain are not recommended unless the lossof consciousness is suspected not to be syncope.

    M. Moodleythat apply to a given patient. Details on the laboratory

    evaluation of syncope are discussed elsewhere in this issue

    by Drs Kuntz and Patwari. Figure 1 gives a user-friendlyemergency department approach to pediatric syncope.

    Tilt Table TestingThe head-up tilt table test as a potential diagnostic tool for

    neurocardiogenic syncope was only introduced in 1986after the ground breaking report by Kenny et al.14 Since

    then several reports have emerged attesting to the utility of

    this test in reproducing syncopal episodes in patients whoare predisposed to neurocardiogenic syncope. The test is

    done by positioning the head of the patient upright at an

    angle of 601-801 for 15-60 minutes on a tilt table with asupporting footboard. A tilt table test result is positive

    when the symptoms of syncope or presyncope are repro-vital signs, search for neurocutaneous lesions, and physical

    features associated with cardiac disease (dysmorphic facial

    features, Marfan syndrome, and Ehlers-Danlos phenotype,deafness etc).12

    Diagnostic EvaluationA detailed history, a comprehensive yet focused clinical

    examination and an EKG have a combined diagnostic yieldof 50%.3 The patient history is the cornerstone on which

    the diagnosis of syncope is made.4 The key historical

    elements to be elicited from patients presenting withsyncope are given in Table 4.

    Diagnostic evaluation should include an EKG on all

    patients with syncope, especially if it occurs with exerciseor is recurrent. All patients with risk factors for cardiac

    disease should be referred to cardiology for further evalua-

    tion. These may include performing echocardiography orusage of Holter or event monitor. Rarely cardiac catheter-

    ization with right ventricular endomyocardial biopsy may

    be necessary before a patient can resume activities.13

    Electroencephalography, neuroimaging studies, and auto-

    nomic function testing (Tilt table, quantitative sudomotor

    axon reflex test) may be indicated with specific neurologicfindings. See Table 5 for a simple diagnostic evaluation of

    pediatric syncope. The history and physical examinationepisodes without injury. Hyperventilation and conversion

    syncope commonly occur in adolescents, usually in a highly

    emotional setting. Both these conditions are rare in childrenyounger than 10 years of age. Unlike typical syncopal

    episodes, conversion syncope is not posture dependent and

    the recovery is often prolonged lasting up to an hour.12 Intrue syncope, consciousness returns within 1 minute of lying

    down, and unconsciousness for more than 5 minutes is rare.11

    In general, a detailed physical examination of patientswith syncope is normal. However, the physical examination

    should be focused to rule out serious cardiac and neuro-

    14duced.4,15 Experience with tilt table testing among pedia-tric populations is limited. Among 54 pediatric patientsminutes was superior to other studies, such as EKG,

    echocardiogram, electroencephalography, or neuroimagingin arriving at a diagnosis of neurocardiogenic syncope.4,16

    The tilt table test has been used in children as young as

    3 years of age.17 However, tilt table testing for neurocar-diogenic syncope in children is relatively new. More

    controlled studies and standardization of degree and

    duration of tilting are necessary to validate the tilt tabletest as a safe, practical, and useful diagnostic tool for

    neurocardiogenic syncope in children.18-21

    As syncope is a relatively common presentation inchildren and the etiology is diverse including seizures,

    pseudosyncope, and metabolic disorders, the evaluation

    may result in unnecessary and costly investigations.22

    Despite exhaustive testing, more than 40% of the patients

    with recurrent syncope do not receive a specific

    diagnosis.17,23

    Table 5 Diagnostic Evaluation of Pediatric SyncopeCBC, complete blood count; CMP, complete metabolic panel; TIBC,total iron binding capacity

  • Clinical approach to syncope in childrenTreatmentThe objective of treatment for neurocardiogenic syncope is

    to prevent recurrent syncope which leads to impairedquality of life, psychological distress, and substantial

    morbidity including frequent absence from school. The

    mainstay of treatment of neurocardiogenic syncope iseducation and counseling of the patient and his or her

    parents.4 The benign nature of these events should be

    explained to the patient and the parents and they should bereassured that these episodes would not result in epilepsy

    or sudden death. Neurocardiogenic syncope almost always

    resolves within months to about 5 years after onset.4,13

    Patients should be encouraged to maintain adequate

    Figure15hydration and enhance dietary salt intake. Patients shouldlearn to recognize and avoid triggers and situations indu-

    cing syncope. If the patients are on hypotensive medica-

    tion, then they should be modified or discontinued. Table 6outlines the nonpharmacologic treatment of neurocardio-

    genic syncope.

    If despite these conservative measures the syncopalepisodes become refractory, pharmacologic therapy may

    be tried. A wide variety of pharmacologic agents are

    currently used for the prevention of recurrent neurocardio-genic syncope in children and adolescents. At the present

    time, b-adrenergic antagonists, fludrocortisone, and mido-drine, an alpha adrenergic receptor agonist, are oftenprescribed in children.24 None of these agents, however,

    1

  • has shown a consistent therapeutic benefit in clinicaltrials.25,26 Low-dose midodrine is promising and is cur-

    rently recommended as first-line therapy for neurocardio-27

    syncope lasts between 5 and 20 seconds, rarely extending2

    tim

    O

    fact that most of the triggering factors are accompanied by a

    age group and is rare in children younger than 10 years2

    Table 6 Nonpharmacologic Treatment of NeurocardiogenicSyncope*

    Education, counseling and reassurance Avoid precipitating or triggering factors Increase water and salt intake

    1.5-2.5 L of water daily At least 2-5 g of salt daily

    Isometric counter pressure maneuvers Leg crossing Buttock tensing Squatting

    Head-up sleeping Abdominal binders, thigh-high or below knee elasticcompression stockings (2030 mm Hg pressure)

    Psychological counseling.*Modified and reprinted with permission.4

    16to minutes. The recovery phase lasts 5-30 minutesassociated with fatigue, dizziness, weakness, headaches,

    and nausea.2 Fortunately the prognosis for recovery is

    excellent in neurocardiogenic syncope. Most patients showspontaneous recovery of their syncope and presyncope

    Table 7 Pharmacologic Treatment of Neurocardiogenic Syncope*

    b-Adrenergic antagonists Atenolol 1-2 mg/kg/dgenic syncope in children by some authorities. Whenusing fludrocortisone it is always advisable to combine it

    with increased salt intake for optimal effect. Table 7 out-

    lines the currently recommended medications for treatmentof neurocardiogenic syncope.

    Prognosis of Neurocardiogenic SyncopeThe actual loss of consciousness in neurocardiogenicpatients especially in young females. Several features help

    hours), during which time there are no cardiovascular or

    Esmolol Metoprolol 1-2 mg/kg/d Nadolol Propranolol 0.5-4 mg/kg/d

    a- Adrenergic agonists Ephedrine Methylphenidate 5-10 mg tid Midodrine 2.510 mg tid Pseudoephedrine 60 mg bid

    Anticholinergics Disopyramide 10-15 mg/kg/d Hyoscine Propantheline Scopolamine

    Selective serotonin receptor reuptake inhibitors Fluoxetine 10-20 mg/d Sertraline 25-50 mg/d

    MineralocorticoidsFludrocortisone 0.1-0.3 mg/d.

    *Modified and reprinted with permission.4neurologic abnormalities and resumption of the supine

    posture does not terminate the event.5. Finally, these patients show remarkable indifference to

    their syncope. During tilt table testing, these patientsdistinguish psychogenic syncope from neurocardiogenic

    syncope4,31,32:

    1. Episodes are extremely frequent (sometimes several

    episodes per day).2. The episodes are usually not associated with injury and

    lack any of the usual precipitating or triggering factors.

    3. Patients experience onset of syncope in the supineposture.

    4. Patients fail to regain consciousness rapidly after a

    syncopal event (occasionally taking as long as severalof age.

    Psychogenic SyncopePatients with pseudosyncope and pseudoseizures typically

    use the event to consciously or unconsciously avoid an

    unpleasant emotional situation.30 Psychogenic syncope isone of the most important causes of syncope in pediatricValsalva maneuver.

    Hyperventilation SyncopeHyperventilation syncope is preceded by symptoms of

    paresthesias, lip tingling, and anxiety or panic attacks.

    The syncopal episode is thought to be secondary tocerebral vasoconstriction triggered by hypocarbia.4

    This type of syncope commonly occurs in the adolescentpredisposition but is a common reason for misdiagnosis of

    pediatric epilepsy.

    Situational SyncopeSituational syncope occurs in close proximity to a specific

    trigger like cough, defecation, micturition, diving, sneezing,trumpet playing, weight lifting, and the Valsalva maneu-

    ver.29 A common denominator in situational syncope is theolo

    cerd spontaneously with no postictal period or postneur-

    gic sequalae. Convulsive syncope results from transient

    ebral ischemia and is not indicative of an epileptic(coanoclonic seizure may accompany a syncopal episode

    nvulsive syncope).28 These convulsions recover rapidlyOc

    mynvulsive Syncopecasionally a brief tonic or rarely a clonic, tonic-clonic, orContinue to show symptoms over an extended period of

    e, often up to 5 years.4,13

    ther Types of Syncopewit

    cohin the first year after onset; 5%-10% would, however,

    M. Moodleymay suddenly faint without any changes in their heartrate and blood pressure.

  • 1. Feit LR: Syncope in the pediatric patient: Diagnosis, pathophysiology,adolescents. J Am Coll Cardiol 29:1039-1045, 1997and treatment. Adv Pediatr 43:469-494, 1996

    2. Fischer JWJ, Cho CS: Pediatric syncope: Cases from the emergency

    department. Emerg Med Clin North Am 28:501-516, 2010

    3. Kaufman H: Evaluation of the patient with syncope In: in Robertons

    D, Biaggioni I, Burnstock G, et al.(eds.), Primer on the Autonomic

    Nervous System, (ed 2) San Diego, CA, Elsevier Academic Press, 2004

    4. Friedman NR, Ghosh D, Moodley M: Syncope and paroxysmal

    disorders other than epilepsy In: in Swaiman K, Ashwal S, Ferriero

    D, Schor N (eds.), Swaimans Textbook of Pediatric Neurology, ed 5

    China; Elsevier, Inc, 2012, pp 905-925

    5. Driscoll Dj, Jacobson SJ, Porter CJ, et al: Syncope in children and

    6. Massin MM, Bourguignont A, Coremans C, et al: Syncope in pediatric

    patients presenting to an emergency department. J PediatrA detailed psychosocial history may provide clues about

    the possible mechanisms involved.4 Many of these indivi-

    duals turn out to have conversion reactions, most fre-quently secondary to sexual abuse. A useful clinical clue to

    the diagnosis is that during pseudosyncope, the eyes are

    usually tightly closed with a lid flutter, whereas duringsyncope the eyes are lightly closed or open and deviated.30

    Many of these patients have syncopal episodes during tilt

    testing without falls in blood pressure or heart rate. Thesepatients will benefit from a referral to a pediatric psychia-

    trist or behavioral specialist.

    ConclusionSyncope is a common presenting problem in children witha wide differential diagnosis. Most causes of syncope are

    benign but rarely may be the first warning sign of a serious

    underlying cardiac or noncardiac disease. The key toidentifying high-risk patients is a detailed history and a

    comprehensive physical examination. This approach willguide practitioners in choosing the diagnostic tests that are

    appropriate for a given patient. Key features in the history

    and physical examination that would prompt a cardiacevaluation include a family history of early sudden cardiac

    death, familial heart disease, known or suspected heart

    disease, exercise induced syncope, syncope triggered byloud noises, fright, extreme emotional stress, or an abnor-

    mal EKG. Syncope must also be differentiated from

    epilepsy and psychogenic pseudosyncope, which areuncommon but important causes of transient alterations

    in the level of consciousness.

    Significant advances in the understanding of syncope ininfants, children and adolescents have occurred in the last

    decade. The management of syncope may be substantially

    enhanced by establishment of a multidisciplinary syncopeevaluation unit or team.

    This unit should set standards of excellence for the

    comprehensive care of the pediatric patient with syncopeand keep abreast of scientific advances in the field so that

    our contributions to patient care, education, and research

    would always be innovative and appropriate to their needs.

    References145:223-228, 20047. Sutton R, Brignole M, Benditt D: The diagnosis and management of

    syncope. Curr Hypertens Rep 12:316-322, 2010

    8. Kapoor WN: Syncope. N Engl J Med 343:1856-1862, 2000

    9. Sutton R: Vasovagal syncope: Clinical features, epidemiology, and

    natural history In: in Blanc JJ, Benditt D, Sutto R (eds.), Neurally

    Mediated Syncope: Pathophysiology, Investigations, and Treatment.

    Armonk, NY, Futura, 1996

    10. Crompton DE, Berkovic SF: The borderland of epilepsy: Clinical and

    molecular features of phenomena that mimic epileptic seizures. Lancet

    Neurol 8:370-381, 2009

    11. Wieling W, Shen WK: Syncope: Approach to management. In: Low PA,

    Benarroch EE (eds): Clinical Autonomic Disorders, ed 3, Baltimore,

    MD, Lippincott, Williams and Wilkins, 2008.

    12. Prodinger RJ, Reisdorff EJ: Syncope in children. Emerg Med Clin

    North Am 16:617-626, 1998

    13. Strieper MJ: Distinguishing benign syncope from life-threatening

    cardiac causes of syncope. Semin Pediatr Neurol 12:32-38, 2005

    14. Kenny RA, Ingram A, Bayliss J, et al: Head-up tile: A useful test for

    investigation unexplained syncope. Lancet 1:1352-1355, 1986

    15. Sra JS, Anderson AJ, Sheikh SH, et al: Unexplained syncope evaluated

    by electrophysiologic studies and head-up tilt testing. Ann Intern Med

    114:1013-1019, 1991

    16. Strieper MJ, Auld DO, Hulse JE, et al: Evaluation of recurrent

    pediatric syncope: Role of tilt table testing. Pediatrics 93:660-662,

    1994

    17. Grubb BR, Orecchio E, Kurczynski TW: Head upright tilt table testing

    in evaluation of recurrent, unexplained syncope. Pediatr Neurol

    8:423-427, 1992

    18. Benditt DG, Lurie KG, Adker SW, et al: Pathophysiology of vasovagal

    syncope In: in Blanc JJ, Benditt D, Sutto R (eds.), Neurally Mediated

    Syncope: Pathophysiology, Investigations, and Treatment. Armonk,

    NY, Futura, 1996

    19. Mansourati J, Blanc JJ: Tilt test procedure: Angle, duration, positive

    criteria In: in Blanc JJ, Benditt D, Sutton R (eds.), Neurally Mediated

    Syncope: Pathophysiology, Investigations, and Treatment. Armonk,

    NY, Futura, 1996

    20. Moya A, Permanyer-Miralda G, Sagrista J, et al: Is there a role for tilt

    testing in the evaluation of treatment of vasovagal syncope? And

    Isoproterenol and tilt test: Protocol, importance, containdications,

    Neurally Mediated Syncope: Pathophysiology, Investigations, and

    Treatment. Armonk, NY, Futura, 1996

    21. Victor J: Tile test. Environment, material, patient preparation In: in

    Blanc JJ, Benditt D, Sutto R (eds.), Neurally Mediated Syncope:

    Pathophysiology, Investigations, and Treatment. Armonk, NY, Futura,

    1996

    22. Landau WM, Nelson DA: Clinical neuromythology XV. Feinting

    science: Neurocardiogenic syncope and collateral vasovagal confusion.

    Neurology 46:609-618, 1996

    23. Kapoor WN: Diagnostic evaluation of syncope. Am J Med 90:91-106, 1991

    24. Massin M: Neurocardiogenic syncope in children: Current concepts in

    diagnosis and management. Pediatr Drugs 5:327-334, 2003

    25. Kaufman H., Freeman R., Pharmacological treatment of reflex

    syncope, Clin Auton Res 2004;14:71-74[Abstract].

    26. Freeman R: A treatment for neurally mediated syncope? (Dont) hold

    your breath. Ann Neurol 37:265-267, 2008

    27. Stewart JM: Midodrine for the treatment of vasovagal syncope (simple

    faint). J Pediatr 149:740-742, 2006

    28. Lin JT, Ziegler DK, Lai CW, et al: Convulsive syncope in blood donors.

    Ann Neurol 11:525-528, 1982

    29. Hannon DW, Knilans TK: Syncope in children and adolescents. Curr

    Probl Pediatr 23:358-384, 1993

    30. Low PA, Benarvoch EE. Clinical Autonomic Disorders. 3rd edition.

    Baltimore, MD, Lippincott William and Wilkins; 2008. pp 490491.

    31. Benbadis SR, Chichkova R: Psychogenic pseudosyncope: An under-

    estimated and provable diagnosis. Epilepsy Behav 1:106-110, 2006

    32. Thijs RD, Bloem BR, van Dijk JG: Falls, faints, fits and funny turns. JClinical approach to syncope in children 17Neurol 256:155-167, 2009

    Clinical Approach to Syncope in ChildrenIntroductionEpidemiologyEtiologyClinical FeaturesDiagnostic EvaluationTilt Table Testing

    TreatmentPrognosis of Neurocardiogenic SyncopeOther Types of SyncopeConvulsive SyncopeSituational SyncopeHyperventilation SyncopePsychogenic Syncope

    ConclusionReferences